Giancarlo Pruneri

29.7k citations
448 papers · 22.8k · 5 hit papers · h-index 76

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 0.1%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis
    • HER2/EGFR in Cancer Research

Papers in

    • Breast Cancer Treatment Studies 70
    • Cancer Genomics and Diagnostics 56
    • Cancer Immunotherapy and Biomarkers 34
    • Cancer-related Molecular Pathways 30
    • Cancer Cells and Metastasis 29
    • HER2/EGFR in Cancer Research 22

Giancarlo Pruneri

428 papers receiving 22.3k citations

Giancarlo Pruneri's Hit Papers

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer 2023 · 227 citations
2270+4+8Years since publication50010001.5k2.0k

Peers

Giancarlo Pruneri
Comparison fields: 5 of 146
  • Cancer Research 6.8k
  • Oncology 9.7k
  • Pathology and Forensic Medicine 3.0k
  • Immunology 2.4k
  • Genetics 1.0k
Replace Filip Jankú with:
Filip Jankú United States
Aurélien de Reyniès France
Luc Yves Dirix Belgium
Apostolia Maria Tsimberidou United States
César A. Moran United States
Sarina Anne Piha-Paul United States
Gerald Steven Falchook United States
Francesco Pezzella United Kingdom
Timothy J. Triche United States
John Milburn Jessup United States
Giancarlo Pruneri relative to Filip Jankú United States Filip Jankú's profile →
Citations per field
00.5×1.5×1.8×
Filip Jankú · 1×
Citations per year

Countries citing papers authored by Giancarlo Pruneri

Since Specialization
Citations

This map shows the geographic impact of Giancarlo Pruneri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giancarlo Pruneri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giancarlo Pruneri more than expected).

Fields of papers citing papers by Giancarlo Pruneri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giancarlo Pruneri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giancarlo Pruneri. The network helps show where Giancarlo Pruneri may publish in the future.

Co-authors

The 25 scholars most cited alongside Giancarlo Pruneri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Giancarlo Pruneri Line = papers co-authored together Giancarlo Pruneri links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 448 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
Hit paper breakdown →
20142466
2
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Hit paper breakdown →
2019651
3
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors
Hit paper breakdown →
2017629
4
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research
Hit paper breakdown →
2017553
5 2018401
6 2001360
7 2010349
8 2017340
9 2018335
10 2004297
11 2016257
12 1999246
13 2008242
14 2016238
15
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
Hit paper breakdown →
2023227
16 2013224
17 2005218
18 2012218
19 2006209
20 2005203

About Giancarlo Pruneri

Giancarlo Pruneri is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 448 papers that have together received 22.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (70 papers), Cancer Genomics and Diagnostics (56 papers), Lymphoma Diagnosis and Treatment (50 papers), Cancer Immunotherapy and Biomarkers (34 papers), Cancer-related Molecular Pathways (30 papers), Cancer Cells and Metastasis (29 papers), HER2/EGFR in Cancer Research (22 papers) and Lung Cancer Treatments and Mutations (21 papers). The work is most often cited by research in Cancer Research (6.8k citations), Oncology (9.7k citations), Pathology and Forensic Medicine (3.0k citations), Immunology (2.4k citations) and Genetics (1.0k citations). Giancarlo Pruneri has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Giuseppe Viale, Francesco Bertolini, Patrizia Mancuso, Giovanni Martinelli, Aron Goldhirsch, Patrick Maisonneuve, Alberto Luini, Nicole Rotmensz, Marco Angelo Colleoni and Nadia Carboni. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Breast Cancer Research and Treatment, International Journal of Cancer and The Breast.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact